SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's to invest up to Rs 600 crore in step-down wholly owned subsidiary

07 Nov 2024 Evaluate

Dr. Reddy's Laboratories has received an approval for the fund infusion by way of investment in equity shares of Dr. Reddy’s Laboratories LLC, Russia, a step-down wholly-owned subsidiary, up to an amount of Rs 600 crore. The fund will be used for working capital requirements.

The Board of Directors of the Company at its meeting held on November 5, 2024, has approved the same.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1337.60 4.55 (0.34%)
24-Apr-2026 13:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1625.55
Dr. Reddys Lab 1337.60
Cipla 1300.65
Zydus Lifesciences 930.65
Lupin 2280.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×